1. Home
  2. WEYS vs AVTX Comparison

WEYS vs AVTX Comparison

Compare WEYS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

SELL

Current Price

$51.69

Market Cap

486.0M

ML Signal

SELL

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

SELL

Current Price

$6.93

Market Cap

426.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WEYS
AVTX
Founded
1906
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
486.0M
426.2M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
WEYS
AVTX
Price
$51.69
$6.93
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $34.80
AVG Volume (30 Days)
36.9K
★ 2.9M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 2.19%
N/A
EPS Growth
N/A
★ 72.07
EPS
★ 3.23
N/A
Revenue
★ $276,169,000.00
$27,813,137.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.87
★ N/A
Revenue Growth
N/A
★ 2312.27
52 Week Low
$28.69
$6.53
52 Week High
$68.39
$24.27

Technical Indicators

Market Signals
Indicator
WEYS
AVTX
Relative Strength Index (RSI) 39.91 33.31
Support Level $50.05 $6.53
Resistance Level $53.83 $8.55
Average True Range (ATR) 3.52 0.64
MACD -0.99 0.25
Stochastic Oscillator 5.25 11.88

Price Performance

Historical Comparison
WEYS
AVTX

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: